Alerts A health worker at the Wits Reproductive Health and HIV Institute (WRHI) in Johannesburg, South Africa showing off a Dapivirine vaginal ring that would be used in an HIV prevention trial on July 20, 2012
Photo: Stephane De Sakutin/AFP (Getty Images)
The next generation of medications and preventative treatments for HIV/AIDS continues to look promising. New research released Tuesday suggests that people can safely wear a vaginal ring-based treatment meant to prevent HIV infection for as long as three months. A monthly version of the same drug is already being weighed for approval in African countries and elsewhere.
Advertisement